Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogeneic Stem Cell Transplant for Renal Cell Cancer and Melanoma
NCT00004135Phase 2Completed
- Sponsor
- University of Chicago
- Start
- Feb 1999
- Primary completion
- Oct 2004
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of peripheral blood stem cells in renal cell carcinoma (RCC), melanoma, sponsored by University of Chicago. Started Feb 1999; status: completed.
02
Drugs
peripheral blood stem cells
03
Conditions
renal cell carcinoma (RCC)melanoma
Beyond the preview
Go deeper on NCT00004135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004135.